EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity

Tong Che, Yixiang Chen, Xinyu Cheng, Han Hu, Xiaoyun Wu, Yuting Zhang, Xiaoqiang Yang, Yinzhen Liu, Hui Liu, Weiwei Nan, Shuangyan Wan, Mingxing Yang und 4 weitere

Acta Pharmaceutica Sinica B · 2026-01 · 16 (1) · 371-386

DOI: 10.1016/j.apsb.2025.10.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-01. Verfasst von Tong Che und 15 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gannan Medical University, National Natural Science Foundation of China, Key Research and Development Program of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AntidepressantAnxiolyticCryo-EMIon channelMacrocyclizationSelectivityStructure-based drug designTRPC5

Autor:innen und Institutionen

  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
  • The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
  • Shenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen 518118, China.
  • Key Laboratory of Medical Electrophysiology, Ministry of Education and Sichuan Province and Institute of Cardiovascular Research, Southwest Medical University, Luzhou 646000, China.
  • Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
  • College of Pharmacy, Gannan Medical University, Ganzhou 341000, China.

Förderung

  • Gannan Medical University
  • National Natural Science Foundation of China
  • Key Research and Development Program of Jiangxi Province
  • Jiangxi Provincial Natural Science Foundation
  • Double Thousand Plan of Jiangxi Province
  • Science Fund for Distinguished Young Scholars of Jiangxi Province

Zitieren

APA

Che, T., Chen, Y., Cheng, X., Hu, H., Wu, X., Zhang, Y., Yang, X., Liu, Y., Liu, H., Nan, W., Wan, S., Yang, M., Zeng, B., Li, J., Zhang, J., & Xiong, B. (2026). Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity. Acta Pharmaceutica Sinica B, 16(1), 371-386. https://doi.org/10.1016/j.apsb.2025.10.028

Vancouver

Che T, Chen Y, Cheng X, Hu H, Wu X, Zhang Y, et al. Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity. Acta Pharmaceutica Sinica B. 2026;16(1):371-386. doi:10.1016/j.apsb.2025.10.028

BibTeX
@article{Che2026,
  author = {Che, Tong and Chen, Yixiang and Cheng, Xinyu and Hu, Han and Wu, Xiaoyun and Zhang, Yuting and Yang, Xiaoqiang and Liu, Yinzhen and Liu, Hui and Nan, Weiwei and Wan, Shuangyan and Yang, Mingxing and Zeng, Bo and Li, Jian and Zhang, Jin and Xiong, Bing},
  title = {Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {371--386},
  doi = {10.1016/j.apsb.2025.10.028}
}
Kostenlos starten →